Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Page Path

HOME
ARTICLE CATEGORY
Review

Review

Current status and strategies for the control of viral hepatitis A in Korea

Eileen L. Yoon, Dong Hyun Sinn, Hyun Woong Lee, Ji Hoon Kim

Clin Mol Hepatol. 2017;23(3):196-204. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0034

View: 9419 Download: 207 Web of Science: 19 Crossref: 20

Current status and strategies for viral hepatitis control in Korea

Dong Hyun Sinn, Eun Ju Cho, Ji Hoon Kim, Do Young Kim, Yoon Jun Kim, Moon Seok Choi

Clin Mol Hepatol. 2017;23(3):189-195. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0033

View: 8957 Download: 244 Web of Science: 20 Crossref: 20

Life-sustaining treatment and palliative care in patients with liver cirrhosis - legal, ethical, and practical issues

Dong Joon Kim, Moon Seok Choi

Clin Mol Hepatol. 2017;23(2):115-122. Published online May 2, 2017

DOI: https://doi.org/10.3350/cmh.2017.0018

View: 9469 Download: 231 Web of Science: 13 Crossref: 15

Radioembolization for the treatment of hepatocellular carcinoma

Hyo-Cheol Kim

Clin Mol Hepatol. 2017;23(2):109-114. Published online May 10, 2017

DOI: https://doi.org/10.3350/cmh.2017.0004

View: 12720 Download: 365 Web of Science: 49 Crossref: 43

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs

Stephen Caldwell

Clin Mol Hepatol. 2017;23(2):103-108. Published online May 10, 2017

DOI: https://doi.org/10.3350/cmh.2017.0103

View: 12672 Download: 479 Web of Science: 32 Crossref: 33

The use of immunosuppression in autoimmune hepatitis: A current literature review

Angela Cropley, Martin Weltman

Clin Mol Hepatol. 2017;23(1):22-26. Published online March 14, 2017

DOI: https://doi.org/10.3350/cmh.2016.0089

View: 29682 Download: 419 Web of Science: 15 Crossref: 18

Anticoagulation in cirrhosis: a new paradigm?

Filippo Leonardi, Nicola De Maria, Erica Villa

Clin Mol Hepatol. 2017;23(1):13-21. Published online March 14, 2017

DOI: https://doi.org/10.3350/cmh.2016.0110

View: 15209 Download: 816 Web of Science: 47 Crossref: 51

Genetic predisposition in nonalcoholic fatty liver disease

Silvia Sookoian, Carlos J. Pirola

Clin Mol Hepatol. 2017;23(1):1-12. Published online March 9, 2017

DOI: https://doi.org/10.3350/cmh.2016.0109

View: 18410 Download: 609 Web of Science: 153 Crossref: 151

Management of direct antiviral agent failures

María Buti, Rafael Esteban

Clin Mol Hepatol. 2016;22(4):432-438. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0107

View: 11413 Download: 365 Web of Science: 29 Crossref: 27

New perspectives of biomarkers for the management of chronic hepatitis B

Chih-Lin Lin, Jia-Horng Kao

Clin Mol Hepatol. 2016;22(4):423-431. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0069

View: 13266 Download: 546 Web of Science: 49 Crossref: 48

Acute kidney injury in liver cirrhosis: new definition and application

Florence Wong

Clin Mol Hepatol. 2016;22(4):415-422. Published online December 14, 2016

DOI: https://doi.org/10.3350/cmh.2016.0056

View: 14402 Download: 760 Web of Science: 55 Crossref: 59

Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment

Hyunwoo Oh, Dae Won Jun, Waqar K Saeed, Mindie H Nguyen

Clin Mol Hepatol. 2016;22(3):327-335. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0049

View: 15928 Download: 535 Web of Science: 51 Crossref: 51

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy

Ioannis Varbobitis, George V. Papatheodoridis

Clin Mol Hepatol. 2016;22(3):319-326. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0045

View: 13680 Download: 402 Web of Science: 70 Crossref: 71

Liver transplantation for advanced hepatocellular carcinoma

Hae Won Lee, Kyung-Suk Suh

Clin Mol Hepatol. 2016;22(3):309-318. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0042

View: 12554 Download: 271 Web of Science: 23 Crossref: 22

Prevention of Hepatitis B reactivation in the setting of immunosuppression

Venessa Pattullo

Clin Mol Hepatol. 2016;22(2):219-237. Published online June 13, 2016

DOI: https://doi.org/10.3350/cmh.2016.0024

View: 17224 Download: 662 Web of Science: 86 Crossref: 89

Current status of laparoscopic liver resection for hepatocellular carcinoma

Hanisah Guro, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, YoungRok Choi, Mohan Periyasamy

Clin Mol Hepatol. 2016;22(2):212-218. Published online June 15, 2016

DOI: https://doi.org/10.3350/cmh.2016.0026

View: 13509 Download: 295 Web of Science: 54 Crossref: 51

Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma

Massimo Roncalli, Amedeo Sciarra, Luca Di Tommaso

Clin Mol Hepatol. 2016;22(2):199-211. Published online May 18, 2016

DOI: https://doi.org/10.3350/cmh.2016.0101

View: 18919 Download: 616 Web of Science: 40 Crossref: 38

KASL clinical practice guidelines: management of hepatitis C

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2016;22(1):76-139. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.76

View: 26690 Download: 209 Web of Science: 64 Crossref: 54

KASL clinical practice guidelines: management of chronic hepatitis B

Clin Mol Hepatol. 2016;22(1):18-75. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.18

View: 25122 Download: 262 Web of Science: 154 Crossref: 136

A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016

Su Jong Yu

Clin Mol Hepatol. 2016;22(1):7-17. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.7

View: 20227 Download: 549 Web of Science: 222 Crossref: 207

Acute-on-chronic liver failure: a new syndrome in cirrhosis

Richard Moreau

Clin Mol Hepatol. 2016;22(1):1-6. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.1

View: 14844 Download: 344 Web of Science: 28 Crossref: 29

Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future

Hyun Young Woo, Jeong Heo

Clin Mol Hepatol. 2015;21(4):344-348. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.344

View: 8488 Download: 199 Web of Science: 29 Crossref: 27

Imaging findings of mimickers of hepatocellular carcinoma

Tae Kyoung Kim, Eunchae Lee, Hyun-Jung Jang

Clin Mol Hepatol. 2015;21(4):326-343. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.326

View: 42664 Download: 991 Web of Science: 24 Crossref: 27

Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase

Yasuko Iwakiri

Clin Mol Hepatol. 2015;21(4):319-325. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.319

View: 12631 Download: 234 Web of Science: 72 Crossref: 79

The mutational landscape of hepatocellular carcinoma

Ju-Seog Lee

Clin Mol Hepatol. 2015;21(3):220-229. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.220

View: 14559 Download: 388 Web of Science: 95 Crossref: 85

Managing alcoholic liver disease

Vijay H. Shah

Clin Mol Hepatol. 2015;21(3):212-219. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.212

View: 9381 Download: 253 Web of Science: 14 Crossref: 14

Personalized management of cirrhosis by non-invasive tests of liver fibrosis

Grace Lai-Hung Wong, Wendell Zaragoza Espinosa, Vicnent Wai-Sun Wong

Clin Mol Hepatol. 2015;21(3):200-211. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.200

View: 9878 Download: 126 Web of Science: 24 Crossref: 26

From DCPD to NTCP: The long journey towards identifying a functional hepatitis B virus receptor

Jisu Li, Shuping Tong

Clin Mol Hepatol. 2015;21(3):193-199. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.193

View: 9044 Download: 203 Web of Science: 9 Crossref: 11

New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis

Hyun Young Woo, Jeong Heo

Clin Mol Hepatol. 2015;21(2):115-121. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.115

View: 10555 Download: 152 Web of Science: 40 Crossref: 31

Hepatitis C virus-induced hepatocellular carcinoma

Nicolas Goossens, Yujin Hoshida

Clin Mol Hepatol. 2015;21(2):105-114. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.105

View: 19075 Download: 342 Web of Science: 115 Crossref: 110

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Impact Factor

14.0
First decision

07 Days

Publication after acceptance

03 Days

*Last 12 months

Viewed By 5841	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5266	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4958	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4934	MAFLD: How is it different from NAFLD?
Viewed By 4560	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 202	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 140	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 119	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 103	MAFLD: How is it different from NAFLD?
Cited By 93	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach